Chanel Inmadar
VP of Investor Relations
Replay available
Zymeworks Inc. (NASDAQ: ZYME) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

VP of Investor Relations
Chair and CEO
Chief Financial Officer
Preclinical Research
SVP and Chief Medical Officer
Head of R&D
Watch the replay and follow the connected company analysis, news, and investor updates for Zymeworks Inc..
WEBVTT 00:00:00.031 -- 00:00:06.278 Good day and thank you for standing by. Welcome to ZymeWorks first quarter 2026 00:00:06.278 -- 00:00:08.921 results conference call. 00:00:08.921 -- 00:00:13.385 At this time, all participants are in the listen only mode. 00:00:13.385 -- 00:00:17.950 After the speaker's presentation, there will be a question and answer session. 00:00:17.950 -- 00:00:24.017 To ask a question during your session, you will need to press star 11 on your telephone. 00:00:24.017 -- 00:00:28.582 You will then hear an automated message advising that your hand is raised. 00:00:28.582 -- 00:00:31.609 To withdraw your question, Please press star 11 again. 00:00:31.609 -- 00:00:33.271 Please 00:00:33.271 -- 00:00:38.095 be advised that today's conference is being recorded. 00:00:38.198 -- 00:00:44.326 I would now like to hand the conference over to your first speaker today, Chanel Inmadar, 00:00:44.326 -- 00:00:49.450 VP of Investor Relations. Your line is open. 00:00:49.694 -- 00:00:54.760 Thank you, Operator. Good afternoon, everyone, and thank you for joining our first quarter 00:00:54.760 -- 00:00:58.317 2026 results conference call. 00:00:58.317 -- 00:01:02.105 As usual, I'd like to remind you that we'll be making a number of forward-looking statements 00:01:02.105 -- 00:01:06.714 during this call, including without limitation those forward-looking statements identified 00:01:06.714 -- 00:01:09.760 on our slides and the accompanying oral commentary. 00:01:09.760 -- 00:01:13.167 These forward-looking statements are based upon our current expectations and various 00:01:13.167 -- 00:01:18.365 assumptions and are subject to the risks and uncertainties including those associated 00:01:18.365 -- 00:01:22.492 with companies in our industry and at our stage of d...